NICOLE SCHNEIDER: Open Payments
NPI 1952999567 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 14 payments from 13 companies in 2025. Trend: 2023 $718 · 2024 $524 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $279 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
| Genmab U.S., Inc. | 1 | $17 |
Products named: RYBREVANT, ZEPZELCA, Nubeqa, Orserdu, Vyloy, Trodelvy, Lenvima, JAKAFI.
Industry payments across DE — which companies pay providers there.
